Impact of a resuscitation protocol prioritizing airway clearance in the COVID-19 pandemic for patients with ventricular fibrillation: a retrospective observational study in Nagoya, Japan

Article information

J EMS Med. 2025;4(2):37-45
Publication date (electronic) : 2025 May 9
doi : https://doi.org/10.35616/jemsm.2024.00129
Department of Emergency and Critical Care, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Correspondence to: Akihiro Kato Department of Emergency and Critical Care, Nagoya City University Graduate School of Medical Sciences, 1-2-23 Wakamizu, Chikusa-ku, Nagoya 464-8547, Japan E-mail: akihiro.k339@gmail.com
Received 2024 November 14; Revised 2025 March 23; Accepted 2025 April 24.

Abstract

Objective

During the coronavirus disease 2019 (COVID-19) pandemic, the prehospital resuscitation protocol in Nagoya was altered to prioritize airway clearance before adrenaline administration to reduce the risk of coronavirus infection. This study evaluated how this protocol change influenced outcomes for patients experiencing out-of-hospital cardiac arrest (OHCA) with an initial waveform of ventricular fibrillation (VF)/pulseless ventricular tachycardia (VT) in Nagoya, Japan.

Methods

We utilized emergency transport data collected by the Nagoya City Fire Bureau. Data from witnessed OHCA cases with an initial waveform of VF/VT were categorized into pre-pandemic (April 1, 2018, to March 31, 2020) and pandemic periods (April 1, 2020, to March 31, 2023). The implementation of the resuscitation protocol and patient outcomes were analyzed.

Results

A total of 371 patients were eligible, with 138 in the pre-pandemic period and 233 during the pandemic. During the pandemic, the interval between the emergency call and hospital arrival increased significantly (23 minutes vs. 25 minutes, P=0.026), as did the interval to adrenaline administration (13 minutes vs. 16 minutes, P<0.001). After propensity score matching for bystander interventions, patient characteristics, and emergency medical services (EMS) contact time, the odds ratio (OR) for prehospital return of spontaneous circulation (ROSC) during the pandemic was significantly lower (OR, 0.57; 95% confidence interval [CI], 0.35–0.94). One-month survival was also significantly lower (OR, 0.58; 95% CI, 0.35–0.94).

Conclusion

Delayed adrenaline administration and EMS contact following protocol changes during the COVID-19 pandemic likely contributed to reduced prehospital ROSC and 1-month survival rates.

INTRODUCTION

In June 2020, during the early stages of the coronavirus disease 2019 (COVID-19) pandemic, the American Heart Association (AHA) recommended securing the airway via tracheal intubation or supraglottic devices prior to establishing intravenous access when resuscitating patients with cardiopulmonary arrest (CA) presenting initially with ventricular fibrillation (VF)/pulseless ventricular tachycardia (VT), aiming to minimize coronavirus transmission [1]. Similarly, Leong et al. [2] emphasized early airway interventions for VF/pulseless VT patients during the COVID-19 pandemic, suggesting that the most experienced paramedics conduct tracheal intubation utilizing video laryngoscopy or similar techniques. While some regions adjusted their resuscitation protocols accordingly, the effects of these changes on emergency medical services (EMS) operations and outcomes for out-of-hospital cardiac arrest (OHCA) patients have not been thoroughly evaluated.

In the Nagoya, the conventional resuscitation protocol for CA patients with VF/VT prioritized defibrillation, followed by intravenous access and adrenaline administration, aiming for an EMS field activity duration of five periods (10 minutes) or less. To reduce the risk of coronavirus transmission, a revised cardiopulmonary resuscitation (CPR) protocol was implemented in August 2020. This modified protocol aimed to shorten field activities to 3–4 periods (6–8 minutes) and required securing the airway using a supraglottic device before establishing intravenous access and administering adrenaline (Fig. 1).

Fig. 1.

Changes in emergency resuscitation protocols during the COVID-19 pandemic period in Nagoya, including measures for infection prevention, early airway clearance, and reduced time spent at the scene. VF, ventricular fibrillation; VT, ventricular tachycardia; CPR, cardiopulmonary resuscitation; IV, intravenous access.

This study examined how changes to the resuscitation protocol during the COVID-19 pandemic affected EMS activities and clinical outcomes among CA patients with VF/VT in Nagoya. Although the protocol underwent changes, we anticipated that the timing of defibrillation would remain unaffected, adrenaline administration would not experience substantial delays, and outcomes such as return of spontaneous circulation (ROSC) or patient survival would not deteriorate.

METHODS

Study design and setting

We retrospectively analyzed emergency medical transport data collected by the Nagoya City Fire Department in Nagoya, Japan. Eligible patients were individuals transported to emergency departments within Nagoya from April 2018 to March 2023 after witnessing CA with an initial waveform of VF/pulseless VT. Patients with cardiac arrest due to non-cardiac causes such as malignancy or poisoning were excluded. Additionally, patients who experienced CA after an emergency call was placed were excluded, since the interval from arrest onset to hospital arrival varied significantly. The pre-pandemic period was defined as April 1, 2018, to March 31, 2020, and the pandemic period was April 1, 2020, to March 31, 2023.

Nagoya has approximately 2.3 million inhabitants and covers an area of 326 km2. Annually, the city receives about 130,000 emergency calls, managed through seven emergency centers [3]. A distinguishing feature of the Nagoya EMS system is the presence of a control system that secures a receiving medical facility upon receiving an emergency call indicating a patient is unconscious or not breathing, even before the EMS team’s arrival. EMS teams in Japan typically consist of three members, with at least one trained paramedic [4]. Permitted resuscitation procedures performed by EMS teams in Japan are limited to defibrillation using an automated external defibrillator, venous cannulation, adrenaline administration, and airway clearance, according to regional protocols. The initiation of venous cannulation, adrenaline administration, and airway management requires verbal authorization from a physician via telephone.

The conventional CA protocol for VF/VT involved defibrillation, venous access, and adrenaline administration within 10 minutes or less. To reduce COVID-19 transmission risks, a revised protocol was implemented, shortening field activity time to 6–8 minutes and prioritizing supraglottic airway management before establishing venous access and administering adrenaline. During the pandemic period, high-efficiency particulate air filters were attached to the bag-valve-mask (BVM) prior to patient contact. Resuscitation was performed in open or well-ventilated areas to reduce the risk of airborne transmission. Patient breathing was assessed solely through visual observation of chest movement, and close physical proximity between the patient and paramedics was minimized. The BVM mask was securely fitted over the patient's mouth and nose, with efforts made to maintain a tight seal during CPR to minimize air leakage. An automated chest compression device was utilized when available to optimize resuscitation quality and reduce direct physical contact.

Data collection

Patient characteristics (age, sex) and EMS process variables, including time to hospital determination, bystander CPR, bystander defibrillation, adrenaline administration timing, and airway management timing, were collected and analyzed for each study period.

Outcome

The primary outcome measures were prehospital ROSC, 1-month survival, and Cerebral Performance Category (CPC) score at 1 month.

Statistical analysis

Continuous variables were analyzed using the Mann-Whitney U test and presented as median values with interquartile ranges. Categorical variables were analyzed using the Fisher exact test and presented as actual counts and percentages. Multivariate logistic regression analysis was performed to identify factors influencing prehospital ROSC. Selected covariates included known influential factors in resuscitation outcomes: pandemic period, age, sex, bystander CPR, bystander defibrillation, and interval to EMS contact. Propensity scores were calculated using logistic regression, adjusting for age, sex (male), bystander CPR, bystander defibrillation, and time interval from witness to EMS contact (minutes). Nearest-neighbor matching (1:1) with a caliper of 0.2 was employed. Standardized mean differences (SMD) were computed to evaluate covariate balance before and after matching; an SMD of less than 0.1 was achieved for all variables, confirming adequate balance post-matching. Statistical significance was defined as a two-tailed P-value of <0.05. All analyses were performed using EZR statistical software (R statistical computing software).

Ethics

This study was approved by the Ethics Committee of Nagoya City University. Eligible patients were offered the opportunity to opt out and not participate in the study if their data were in the pre-processing stage.

RESULTS

There were 553 patients whose cardiac arrests were witnessed and who had an initial waveform of VF/VT (Fig. 2). After excluding 56 patients with non-cardiac causes and 126 who experienced cardiac arrest after the emergency call was placed, 371 eligible patients remained. There were 138 patients in the pre-pandemic period and 233 in the pandemic period.

Fig. 2.

Inclusion criteria. VF, ventricular fibrillation; VT, ventricular tachycardia.

Table 1 presents patient characteristics, bystander intervention rates, EMS activation times, and interventions for each period. The median patient age was 66 years (interquartile range, 54–74 years) in the pre-pandemic period and 68 years (interquartile range, 56–75 years) in the pandemic period. The number and proportion of males in the pre-pandemic period were 115 (83.3%), which was not significantly different from the pandemic period (n=199, 85.4%). The rates of bystander CPR and defibrillation did not differ significantly between the two periods. During the pandemic period, the interval from the emergency call to hospital determination, the interval from the emergency call to EMS contact, and the interval from scene departure to hospital arrival were significantly prolonged. Consequently, the total EMS activity interval from the emergency call to hospital arrival was delayed by approximately 2 minutes (pre-pandemic vs. pandemic: 23 minutes vs. 25 minutes, P=0.026). Hereafter, all data values are presented as pre-pandemic versus pandemic period values. The duration of EMS on-scene activity did not significantly differ between periods (11 minutes vs. 11 minutes, P=0.206). The rate of airway clearance performed using a closed esophageal airway was significantly higher during the pandemic period (63.5% vs. 73.4%, P=0.047). Fig. 3 displays a box-and-whisker diagram showing intervals related to resuscitation procedures. The interval from the emergency call to adrenaline administration was significantly longer during the pandemic period (13 minutes vs. 16 minutes, P<0.001).

Patient characteristics, resuscitation procedures, and time course related to EMS

Fig. 3.

Box-and-whisker plots depicting time intervals associated with specific aspects of resuscitation procedures for each study period. The defibrillation interval represents the duration from witnessed collapse to the first administered shock. Intervals for airway clearance and adrenaline administration are measured from the time of the emergency call. The boxes represent interquartile ranges, horizontal lines within boxes indicate median values, and whiskers denote maximum and minimum observed values.

Table 2 shows the prehospital ROSC rate, 1-month survival rate, and neurological outcomes. The rate of prehospital ROSC was significantly lower during the pandemic period (54.3% vs. 43.3%, P=0.042). Similarly, the survival rate at 1 month was lower during the pandemic period (57.2% vs. 46.4%, P=0.053), though not significantly. The proportion of patients with CPC scores of 1–2 at 1 month was also lower during the pandemic, but this difference was not statistically significant (36.2% vs. 30.9%, P=0.31).

Outcomes of patients in each period

Table 3 presents the adjusted odds ratios (ORs) for factors influencing prehospital ROSC. The OR for achieving ROSC during the pandemic period compared to the pre-pandemic period was 0.67 (95% confidence interval [CI], 0.43–1.03). Bystander CPR was significantly associated with increased odds of ROSC (OR, 2.33; 95% CI, 1.46–3.71). The interval in minutes from witness to EMS contact was inversely associated with prehospital ROSC (OR, 0.94; 95% CI, 0.88–0.99).

Adjusted ORs and 95% CIs for prehospital ROSC

Table 4 compares prehospital ROSC, survival at 1 month, and CPC 1–2 outcomes after propensity score matching. After adjusting for covariates including age, sex (male), bystander CPR, bystander defibrillation, and the interval between witness and EMS contact (minutes), the prehospital ROSC rate during the pandemic period was significantly lower (OR, 0.57; 95% CI, 0.35–0.94), as was 1-month survival (OR, 0.58; 95% CI, 0.35–0.94). Although the proportion of patients with CPC scores of 1–2 at 1 month was also lower during the pandemic, this difference did not reach statistical significance (OR, 0.67; 95% CI, 0.39–1.14).

Comparison of ROSC, survival, and CPC 1–2 after propensity score matching

DISCUSSION

In our study of CA patients with an initial waveform of VF/VT, the total EMS activity time—from emergency call to hospital arrival—increased by approximately 2 minutes during the COVID-19 pandemic. However, EMS on-scene activity duration was not prolonged. The rates of prehospital ROSC and 1-month survival were significantly lower during the pandemic period.

Changes in the prehospital activity time during the COVID-19 pandemic

Regarding the total prehospital interval from emergency call to hospital arrival, Katasako et al. [5] analyzed nationwide OHCA registry data from Japan and reported a delay of approximately 1 minute, from 31 minutes in the pre-pandemic period to 32 minutes during the pandemic. In our Nagoya-based study, total prehospital activity time increased by 2 minutes, from 23 minutes in the pre-pandemic period to 25 minutes in the pandemic period. Even during the pandemic, Nagoya maintained a shorter overall prehospital activity duration, a distinctive feature attributed to the city’s advanced control system, which ensures hospital selection before EMS arrival. In a comparative study of EMS in other Asian cities, the interval to patient contact was reported as 5.7 minutes in Seoul, 8.2 minutes in Singapore, and 12.5 minutes in Bangkok, indicating Nagoya’s relatively rapid EMS response [6]. However, during the COVID-19 pandemic, the hospital selection interval increased significantly due to heightened demand for EMS services. This resulted in more frequent dispatches to remote scenes and longer transport distances to receiving hospitals, extending total prehospital activity time by approximately 2 minutes, although on-scene EMS duration remained unchanged. Multivariate analysis in our study indicated that bystander CPR and earlier EMS contact positively influenced prehospital ROSC outcomes. Given that rates of bystander CPR and defibrillation did not differ significantly between the pre-pandemic and pandemic periods, delayed EMS contact likely contributed to the decreased prehospital ROSC rates observed among CA patients with VF/VT.

EMS protocol changes and prognostic impact

To reduce COVID-19 transmission risks to EMS personnel, Nagoya modified its CPR protocol during the pandemic, prioritizing device-assisted airway clearance over adrenaline administration, along with implementing a policy to minimize on-scene activity duration. These changes resulted in increased utilization of closed esophageal airways and decreased intervals to airway clearance using these devices. However, the interval to adrenaline administration increased by approximately 3 minutes during the pandemic period. Although the COVID-19 protocol anticipated adrenaline administration timing similar to the conventional protocol, delays likely arose from the additional time needed for EMS personnel to don full personal protective equipment (PPE). Consequently, adherence to the established activity time limits of the new protocol resulted in reduced rates and delayed timing of adrenaline administration during the pandemic.

Among OHCA patients, a recent randomized controlled trial demonstrated non-inferiority of endotracheal intubation compared to bag-mask ventilation regarding 28-day neurologically favorable survival outcomes [7]. Differences in airway management methods thus may not significantly affect the prognosis of VF patients. In Australia, a significant increase in laryngeal mask airway use among EMS-witnessed OHCA patients occurred during the pandemic period (39.3% pre-pandemic vs. 61.1% pandemic, P<0.001), yet survival-to-discharge rates showed no significant differences (30.3% vs. 32.8%, P=0.16) [8]. Multiple reports similarly suggest that increased use of supraglottic airway devices during the COVID-19 pandemic did not appear to improve prognosis in OHCA patients.

Conversely, recent evidence suggests an association between delayed adrenaline administration and poorer clinical outcomes. In Canada, the interval from EMS arrival on scene to supraglottic airway device insertion decreased slightly during the pandemic period (11 minutes vs. 10 minutes, P<0.01), whereas the interval to adrenaline administration increased (11 minutes vs. 13 minutes, P<0.01). Furthermore, the rate of adrenaline administration also declined (69% vs. 65%, P<0.01) [9]. This resulted in a lower prehospital ROSC rate during the pandemic period (33.5% pre-pandemic vs. 29.7% pandemic), mirroring trends observed in our study.

Although adrenaline administration has traditionally been considered to increase the rates of ROSC and survival in CA patients without significantly improving neurological outcomes, recent studies have suggested that earlier administration of adrenaline might improve neurological outcomes. A propensity score-matched cohort study utilizing the Japanese registry for OHCA patients with all waveform types showed that delaying adrenaline administration beyond 20 minutes after an emergency call significantly reduced the proportion of patients with CPC scores of 1–2 at 1 month, compared to those receiving adrenaline within 20 minutes (0.8% vs. 2.2%; relative risk, 0.34; 95% CI, 0.30–0.39) [10]. Furthermore, among OHCA patients with shockable rhythms, a time-dependent propensity score analysis indicated that each additional minute of delay in adrenaline administration after EMS arrival decreased the 1-month survival rate by 5.5% (95% CI, 3.4%–7.5%; P<0.001 for interaction between adrenaline administration and matching time) [11]. In our study, the pandemic period was associated with a 3-minute delay in adrenaline administration, which might have contributed to the observed lower survival rate at 1 month (57.2% vs. 46.4%) and lower prehospital ROSC rate (54.3% vs. 43.3%) among CA patients with VF/VT.

The 2024 International Liaison Committee on Resuscitation (ILCOR) guidelines do not specifically reference COVID-19 or pandemics [12]. According to the 2023 ILCOR consensus, although PPE use during the pandemic increased rescuer fatigue, it did not negatively impact 30-day survival rates or ROSC in OHCA cases [13]. Consequently, the continued use of PPE is recommended for infection control. While the AHA issued temporary guidance during the early stages of the pandemic, no subsequent revisions have been made to the 2020 resuscitation algorithm. Our findings suggest that prioritizing airway management within the protocol might worsen patient outcomes, indicating the need for further research into this approach.

Limitations

Because this was an observational study, several risks of bias exist. Patient comorbidities were unknown, potentially introducing variability in patient characteristics. Additionally, we did not evaluate the quality of chest compressions or ventilation delivered during resuscitation. Ideally, to accurately examine prognostic factors such as the timing of adrenaline administration, a time-dependent propensity matching approach would have been preferable to control for biases related to resuscitation timing; however, the limited number of patients in our study precluded the use of this method. Information regarding the location of EMS dispatch or the identity of the individual who discovered the patient was unavailable, limiting detailed examination of life-saving interventions performed by bystanders. In-hospital treatment details were also unavailable, and thus, the data derived from prehospital activities alone were insufficient for thoroughly evaluating patient prognoses at 1 month.

In summary, we comprehensively analyzed EMS prehospital activities and outcomes for CA patients initially presenting with VF/VT in Nagoya. During the COVID-19 pandemic period, intervals from emergency call to EMS contact and hospital arrival were prolonged, and prehospital ROSC rates decreased. Delays in EMS contact and adrenaline administration resulting from changes to the resuscitation protocol prioritizing airway clearance likely influenced the lower prehospital ROSC rates observed among VF/VT patients during the pandemic.

Notes

FUNDING

None.

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

AUTHORS’ CONTRIBUTIONS

Conceptualization: AK, AM; Data curation: AK, AM; Formal analysis: AK, AM; Methodology: all authors; Project administration: all authors; Resources: all authors; Supervision: AM; Validation: all authors; Writing–original draft: EAT, SW; Writing–review & editing: all authors.

ACKNOWLEDGEMENTS

We thank the Nagoya City Fire Department for providing the data and thank the medical control conference in Nagoya for the comments about our results.

References

1. Edelson DP, Sasson C, Chan PS, et al. Interim guidance for basic and advanced life support in adults, children, and neonates with suspected or confirmed COVID-19: from the Emergency Cardiovascular Care Committee and Get with the Guidelines-Resuscitation Adult and Pediatric Task Forces of the American Heart Association. Circulation 2020;141:e933–43. 10.1161/CIRCULATIONAHA.120.047463. 32270695.
2. Leong YC, Cheskes S, Drennan IR, Buick JE, Latchmansingh RG, Verbeek PR. Clinical considerations for out-of-hospital cardiac arrest management during COVID-19. Resusc Plus 2020;4:100027. 10.1016/j.resplu.2020.100027. 33403363.
3. Nagoya City: Nagoya City Hall. Emergency Statistics [Internet]. Nagoya City Hall; 2024. [cited 2024 Nov 8]. Available from: https://www.city.nagoya.jp/shobo/page/0000101121.html.
4. Tanigawa K, Tanaka K. Emergency medical service systems in Japan: past, present, and future. Resuscitation 2006;69:365–70. 10.1016/j.resuscitation.2006.04.001. 16740355.
5. Katasako A, Yoshikawa Y, Noguchi T, et al. Changes in neurological outcomes of out-of-hospital cardiac arrest during the COVID-19 pandemic in Japan: a population-based nationwide observational study. Lancet Reg Health West Pac 2023;36:100771. 10.1016/j.lanwpc.2023.100771. 37360869.
6. Lin CH, Ng YY, Chiang WC, et al. Variation of current protocols for managing out-of-hospital cardiac arrest in prehospital settings among Asian countries. J Formos Med Assoc 2016;115:628–38. 10.1016/j.jfma.2015.10.003. 26596689.
7. Jabre P, Penaloza A, Pinero D, et al. Effect of bag-mask ventilation vs endotracheal intubation during cardiopulmonary resuscitation on neurological outcome after out-of-hospital cardiorespiratory arrest: a randomized clinical trial. JAMA 2018;319:779–87. 10.3410/f.732756803.793544332. 29486039.
8. Kennedy C, Alqudah Z, Stub D, Anderson D, Nehme Z. The effect of the COVID-19 pandemic on the incidence and survival outcomes of EMS-witnessed out-of-hospital cardiac arrest. Resuscitation 2023;187:109770. 10.1016/j.resuscitation.2023.109770. 36933880.
9. Armour R, Ghamarian E, Helmer J, et al. Impact of the COVID-19 pandemic on Canadian emergency medical system management of out-of-hospital cardiac arrest: a retrospective cohort study. Resuscitation 2024;194:110054. 10.1016/j.resuscitation.2023.110054. 37992799.
10. Fukuda T, Ohashi-Fukuda N, Inokuchi R, Kondo Y, Taira T, Kukita I. Timing of Intravenous epinephrine administration during out-of-hospital cardiac arrest. Shock 2021;56:709–17. 10.1097/shk.0000000000001731. 33481550.
11. Okubo M, Komukai S, Callaway CW, Izawa J. Association of timing of epinephrine administration with outcomes in adults with out-of-hospital cardiac arrest. JAMA Netw Open 2021;4e2120176. 10.1001/jamanetworkopen.2021.20176. 34374770.
12. Greif R, Bray JE, Djarv T, et al. 2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations: Summary from the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces. Circulation 2024;150:e580–687. 10.1161/CIR.0000000000001288. 39540293.
13. Berg KM, Bray JE, Ng KC, et al. 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations: Summary from the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces. Circulation 2023;148:e187–280. 10.1161/CIR.0000000000001179. 37942682.

Article information Continued

Fig. 1.

Changes in emergency resuscitation protocols during the COVID-19 pandemic period in Nagoya, including measures for infection prevention, early airway clearance, and reduced time spent at the scene. VF, ventricular fibrillation; VT, ventricular tachycardia; CPR, cardiopulmonary resuscitation; IV, intravenous access.

Fig. 2.

Inclusion criteria. VF, ventricular fibrillation; VT, ventricular tachycardia.

Fig. 3.

Box-and-whisker plots depicting time intervals associated with specific aspects of resuscitation procedures for each study period. The defibrillation interval represents the duration from witnessed collapse to the first administered shock. Intervals for airway clearance and adrenaline administration are measured from the time of the emergency call. The boxes represent interquartile ranges, horizontal lines within boxes indicate median values, and whiskers denote maximum and minimum observed values.

Table 1.

Patient characteristics, resuscitation procedures, and time course related to EMS

Characteristic Pre-pandemic period (n=138) Pandemic period (n=233) P-value
Age (yr) 66 (54–74) 68 (56–75) 0.343
Male sex 115 (83.3) 199 (85.4) 0.655
Bystander CPR 92 (66.7) 156 (67.0) 1.000
Bystander defibrillation 13 (9.4) 22 (9.4) 1.000
Initial ECG waveform
 VF 137 (99.3) 232 (99.6) 1.000
 Pulseless VT 1 (0.7) 1 (0.4)
Defibrillation 123 (89.1) 225 (96.6) 0.006
Number of prehospital defibrillations 3 (1–4) 2 (1–4) 0.445
Adrenaline administration 47 (34.1) 64 (27.5) 0.198
Type of airway secured
 Supraglottic airway 87 (63.5) 171 (73.4) 0.047
 Other methods 51 (36.5) 62 (26.6)
Time to determine receiving hospital (min) 1 (1–1) 1 (1–2) <0.001
 Interval between witnessed event and emergency call 2 (1–3) 2 (1–3) 0.554
 Interval between emergency call and EMS arrival on the scene 5 (4–6) 6 (5–7) 0.003
 Interval between emergency call and EMS contact 6 (5–8) 8 (6–9) <0.001
 Interval on the scene 11 (8–15) 11 (8–13) 0.206
 Interval between the scene and hospital 6 (4–9) 8 (6–11) <0.001
 Interval between emergency call and hospital 23 (20–28) 25 (21–29) 0.026
 Interval between witnessed event and hospital 26 (21–31) 27 (23–32) 0.058
 Interval between witness and first defibrillation 9 (8–12) 10 (8–12) 0.214
 Interval between emergency call and adrenaline administration 13 (12–15) 16 (14–20) <0.001
 Interval between emergency call and airway clearance 13 (12–15) 12 (11–15) 0.171

Values are presented as median (interquartile range) or number (%).

EMS, emergency medical services; CPR, cardiopulmonary resuscitation; ECG, electrocardiogram; VF, ventricular fibrillation; VT, ventricular tachycardia.

Table 2.

Outcomes of patients in each period

Variable Pre-pandemic period (n=138) Pandemic period (n=233) P-value
Prehospital ROSC 75 (54.3) 101 (43.3) 0.042
Initial ROSC location
 Prehospital 75 (54.3) 101 (43.3) 0.065
 Hospital 37 (26.8) 66 (28.3)
 Non-ROSC 26 (18.8) 66 (28.3)
CPC 1–2 after 1 mo 50 (36.2) 72 (30.9) 0.305
Survival after 1 mo 79 (57.2) 108 (46.4) 0.053
CPC after 1 mo
 1 37 (26.8) 55 (23.6) 0.317
 2 13 (9.4) 17 (7.3)
 3 14 (10.1) 16 (6.9)
 4 15 (10.9) 20 (8.6)
 5 59 (42.8) 125 (53.6)

Values are presented as number (%).

ROSC, return of spontaneous circulation; CPC, Cerebral Performance Category.

Table 3.

Adjusted ORs and 95% CIs for prehospital ROSC

Variable OR 95% CI P-value
Pandemic period 0.67 0.43–1.03 0.070
Age 1.00 0.99–1.01 0.813
Male sex 0.95 0.53–1.70 0.852
Bystander CPR 2.33 1.46–3.71 <0.001
Bystander defibrillation 1.39 0.67–2.91 0.379
Interval between witness and EMS contact 0.94 0.88–0.99 0.017

OR, odds ratio; CI, confidence interval; ROSC, return of spontaneous circulation; CPR, cardiopulmonary resuscitation; EMS, emergency medical service.

Table 4.

Comparison of ROSC, survival, and CPC 1–2 after propensity score matching

Variable Pre-pandemic period (n=131) Pandemic period (n=131) OR 95% CI P-value SMD
Age (yr) 67 (55.5–74.5) 66 (54.5–76.0) - - 0.944 0.059
Male sex 109 (83.2) 109 (83.2) - - 1.000 <0.001
Bystander CPR 89 (67.9) 85 (64.9) - - 0.695 0.065
Bystander defibrillation 12 (9.2) 12 (9.2) - - 1.000 <0.001
Interval between witness and EMS contact (min) 9 (7–11) 9 (7–11) - - 0.432 0.070
Prehospital ROSC 73 (55.7) 55 (42.0) 0.57 0.35–0.94 0.036 -
Survival after 1 mo 74 (56.5) 56 (42.7) 0.58 0.35–0.94 0.036 -
CPC 1–2 after 1 mo 45 (34.4) 34 (26.0) 0.67 0.39–1.14 0.178 -

Values are presented as median (interquartile range) or number (%).

ROSC, return of spontaneous circulation; CPC, Cerebral Performance Category; OR, odds ratio; CI, confidence interval; SMD, standardized mean difference; CPR, cardiopulmonary resuscitation; EMS, emergency medical service.